Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2023 and Recommend dividend, if any, for the financial year ended 31st March, 2023 and any other business items as per agenda circulated. Further, in continuation of our earlier intimation dated March 31, 2023, in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations and in pursuant to Companies Code of Conduct for prevention of Insider Trading in Shares of the Company, the Trading window for dealing in the securities of the Company for all the designated persons including insiders has already been closed w.e.f 31st March, 2023 and the same shall be closed till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and year ended March 31, 2023.